dosing | CARLAT PUBLISHING

Stimulant Dosing

February 19, 2024

Chris Aiken, MD and Kellie Newsome, PMHNP

Dosing is not a collaborative venture when it comes to controlled substances, and here we look for the safe upper limits of stimulant dosing.

Expert Q&A

Psychedelic-Assisted Psychotherapy

June 1, 2023

Jeffrey Guss, MD

Jeffrey Guss, MD.

Psychiatrist and psychoanalyst. Clinical Assistant Professor of Psychiatry at NYU Grossman School of Medicine. Faculty at the NYU Postdoctoral Program in Psychotherapy and Psychoanalysis.

Dr. Guss has no financial relationships with companies related to this material.

What actually happens during psychedelic psychotherapy? Dr. Guss walks us through the steps.
1) preparation, 2) dosing, and 3) integration, where the insights gained from psychedelic experiences are turned into action in the real world.

Clinical Update

A Psychedelic Primer

June 1, 2023

Chris Aiken, MD and Garrett Rossi, MD.

Chris Aiken, MD. Editor-in-Chief of The Carlat Psychiatry Report. Assistant Professor, NYU Langone Department of Psychiatry. Practicing psychiatrist, Winston-Salem, NC.

Garrett Rossi, MD. Inpatient/Consult Attending Psychiatrist, AtlantiCare Regional Medical Center, Pomona, NJ.

The authors have no financial relationships with companies related to this material.

How did a dangerous drug of abuse become a therapeutic panacea?

Clinical Update

Treatment of Antipsychotic-Induced Weight Gain

September 1, 2022

Brian Miller, MD, PhD, MPH

Brian Miller, MD, PhD, MPH. Professor of Psychiatry at the Medical College of Georgia, Augusta, and President of the Georgia Psychiatric Physicians Association.

Dr. Miller, author of this educational activity, receives research support from Augusta University; the National Institute of Mental Health; the Brain and Behavior Research Foundation; and the Stanley Medical Research Institute. Relevant financial relationships listed for the author have been mitigated.

From lifestyle changes to liraglutide, Brian Miller details best practices for managing this insidious side effect.

CLINICAL UPDATE

Six Tips From Prescribing Psychotropics

August 1, 2022

Chris Aiken, MD

Chris Aiken, MD.

Editor-in-Chief of The Carlat Psychiatry Report. Practicing psychiatrist, Winston-Salem, NC.

Dr. Aiken, author for this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

New answers to age-old questions, such as adjusting the dose to account for drug interactions, reducing side effects, maintaining weight, and protecting that finicky organ—the kidneys.

Quetiapine Reconsidered

June 1, 2022

Paul Riordan, MD.

Paul Riordan, MD. Assistant Consulting Professor of Psychiatry, Duke University. Dr. Riordan has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

It is the best of drugs; it is the worst of drugs. Quetiapine (Seroquel) has a few benefits that are unmatched by other medications, and here we explore where it fits in depression, bipolar, schizophrenia, as well as off-label uses like anxiety and sleep.

Tricyclic Antidepressants: When and How to Use Them

May 1, 2022

Edmund S. Higgins, MD. Clinical associate professor, Psychiatry and Behavioral Sciences, Medical University of South Carolina. Dr. Higgins has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Tricyclics have been used in psychiatry since the 1950s, when imipramine was introduced as the first mass-marketed antidepressant. Fluoxetine and the other SSRIs largely supplanted the tricyclics in the 1990s, but these medications still have their uses.

Establishing a Dose-Response Relationship for Lurasidone in Acute Schizophrenia

November 5, 2021

Garrett Rossi, MD.

Garrett Rossi, MD. Dr. Rossi has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Study suggests we may be underdosing this antipsychotic in schizophrenia.

Tips on the Doubts about Ketamine/Esketamine

August 19, 2020

Ketamine and esketamine have been shown to provide rapid relief of suicidality, however, many lingering doubts have been raised about these medicines. In a previous article from The Carlat Psychiatry Report, Nolan Williams, M.D., discusses the potential negative consequences of ketamine/esketamine treatment. Here are some of Dr. Williams’s tips:It might...

How to Dose an Antidepressant

April 3, 2020

Some antidepressants get better as the dose goes higher, while others just fizzle. For older patients, the side effects stack up as the benefits plateau. We review 3 new meta-analyses on antidepressant dosing, and bring you 4 updates on how the coronavirus is changing practice regulation.Date Published: 3/30/2020Duration: 27 minutes,...